These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10592542)

  • 1. [Pharmaco-erection in erectile deficiency after surgical therapy].
    Favre M; Enria T
    Arch Ital Urol Androl; 1999 Sep; 71(4):253-5. PubMed ID: 10592542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current role of intracavernous therapy in the treatment of erectile dysfunction].
    Asuar Aydillo S
    Arch Esp Urol; 2002 Jun; 55(5):475-82. PubMed ID: 12174413
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction.
    Meinhardt W; de la Fuente RB; Lycklama à Nijeholt AA; Vermeij P; Zwartendijk J
    Int J Impot Res; 1996 Mar; 8(1):5-7. PubMed ID: 8735187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of a second injection on the pharmaco-induced erection test.
    Pagani E; Puech-Leão P; Glina S; Reis JM
    Int J Impot Res; 1997 Sep; 9(3):167-8. PubMed ID: 9315495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of satisfactory rigidity after intracavernosal injection with prostaglandin E1 in men with erectile failure.
    Purvis K; Brekke I; Christiansen E
    Int J Impot Res; 1996 Mar; 8(1):9-16. PubMed ID: 8735188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transurethral alprostadil as therapy for patients who withdrew from or failed prior intracavernous injection therapy.
    Engel JD; McVary KT
    Urology; 1998 May; 51(5):687-92. PubMed ID: 9610580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term intracavernous therapy responders can potentially switch to sildenafil citrate after radical prostatectomy.
    Raina R; Lakin MM; Agarwal A; Ausmundson S; Montague DK; Zippe CD
    Urology; 2004 Mar; 63(3):532-7; discussion 538. PubMed ID: 15028452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erectile dysfunction: intracavernous treatment.
    Ledda A
    Curr Med Res Opin; 2000; 16 Suppl 1():s59-62. PubMed ID: 11329824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracavernous injections for erectile dysfunction in patients with cardiovascular diseases and failure or contraindications for sildenafil citrate.
    Israilov S; Niv E; Livne PM; Shmueli J; Engelstein D; Segenreich E; Baniel J
    Int J Impot Res; 2002 Feb; 14(1):38-43. PubMed ID: 11896476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacotherapy of erectile dysfunction].
    Shcheplev PA; Nesterov SN; Kukharkin SA; Abdullaev IA; Sidorov DV
    Ter Arkh; 1999; 71(10):76-8. PubMed ID: 10612182
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diagnosis and treatment of erectile dysfunction].
    Loran OB; Sheplev PA; Nesterov SN
    Urol Nefrol (Mosk); 1998; (3):39-46. PubMed ID: 9644990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erectile dysfunction in spinal cord injury: a cost-utility analysis.
    Mittmann N; Craven BC; Gordon M; MacMillan DH; Hassouna M; Raynard W; Kaiser A; Lanctôt LK; Tarride JE
    J Rehabil Med; 2005 Nov; 37(6):358-64. PubMed ID: 16287667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with intracavernous injection in the treatment of erectile dysfunction after radical prostatectomy: dose considerations.
    Chuang FP; Lakin M; Wu ST; Cha TL; Sun GH; Montague DK
    Int J Impot Res; 2011; 23(4):146-50. PubMed ID: 21654813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of 452 patients with erectile dysfunction treated by combinations of vasoactive agents by penile injection].
    Segenreich E; Israilov S; Shmueli J; Simon D; Baniel J; Livne P
    Harefuah; 1998 May; 134(9):673-8, 750. PubMed ID: 10909609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Penile self-injection of a papaverine-phentolamine combination, as treatment of impotence, in patients treated with radical cystoprostatectomy].
    Calahorra Fernández FJ; Rodríguez A; Castro M; Tamayo JC; Alvarez E; Leiva O
    Actas Urol Esp; 1991; 15(1):43-5. PubMed ID: 2058441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Response to intracavernous administration of 3 different drugs in the same group of patients with erectile dysfunction].
    Ribé N; Rajmil O; Bassas L; Jurado C; Pomerol JM
    Arch Esp Urol; 2001 May; 54(4):355-9. PubMed ID: 11455770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracavernosal injection and intraurethral therapy for erectile dysfunction.
    Leungwattanakij S; Flynn V; Hellstrom WJ
    Urol Clin North Am; 2001 May; 28(2):343-54. PubMed ID: 11402586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracavernous chlorpromazine versus phentolamine: a double-blind clinical comparative study.
    Shamloul R; El-Dakhly M; Ghanem H; Gadallah A; Mokhtar H
    J Sex Med; 2004 Nov; 1(3):310-3. PubMed ID: 16422961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intracavernous injection of vasoactive drugs for treating erectile impotence].
    Yasumoto R; Asakawa M; Kawashima H; Yoshimura R; Maekawa T; Kashiwara N; Tanaka H; Nishio S
    Hinyokika Kiyo; 1988 Feb; 34(2):301-4. PubMed ID: 2454019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy for erectile dysfunction: a randomized, double blind, unblinded active-controlled, cross-over study of the pharmacodynamics and safety of combined oral formulations of apomorphine hydrochloride, phentolamine mesylate and papaverine hydrochloride in men with moderate to severe erectile dysfunction.
    Lammers PI; Rubio-Aurioles E; Castell R; Castaneda J; Ponce de Leon R; Hurley D; Lipezker M; Loehr LA; Lowrey F
    Int J Impot Res; 2002 Feb; 14(1):54-9; discussion 60. PubMed ID: 11896479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.